974,817 views
Video Summary: What are Embryonic Stem Cells
Could the cure for Type 1 diabetes come from a five-day-old embryo? Embryonic stem cells are remarkable undifferentiated cells harvested from blastocysts that possess the extraordinary ability to become any cell type in the human body. These pluripotent powerhouses are currently being studied by researchers at Stanford University and other leading institutions for treating spinal cord injuries and neurodegenerative diseases. Watch the full video on JoVE Coach to master this concept with expert-led visuals and step-by-step explanations.
Embryonic stem cells represent one of biology's most fascinating and promising discoveries. These extraordinary cells emerge during the earliest stages of human development, specifically from the inner cell mass of a blastocyst-a hollow sphere of cells that forms 3-5 days after fertilization. Unlike adult stem cells, which have limited differentiation potential, embryonic stem cells are pluripotent, meaning they can theoretically develop into any of the approximately 220 different cell types found in the human body.
The remarkable versatility of embryonic stem cells stems from their unique genetic programming. These cells express specific transcription factors, including Oct4, Sox2, and Nanog, which maintain their undifferentiated state while preserving their developmental potential. When researchers manipulate culture conditions-adding specific growth factors like bone morphogenetic proteins (BMPs) or activin-they can guide these cells down particular developmental pathways. For example, adding insulin-like growth factor can promote neural differentiation, while specific cytokines can encourage cardiac muscle formation.
This controlled differentiation process is crucial for understanding both normal development and disease mechanisms. Students preparing for the MCAT or AP Biology exams should recognize that this represents a practical application of gene expression regulation and cell signaling pathways covered in their coursework.
Leading research institutions across the United States, including the Mayo Clinic, Johns Hopkins, and the University of California system, are actively investigating embryonic stem cell therapies. Current clinical trials focus on treating conditions like macular degeneration, spinal cord injuries, and Parkinson's disease. The FDA has approved several embryonic stem cell-derived therapies, marking significant progress in translating laboratory research into patient care.
One particularly promising application involves creating insulin-producing beta cells for Type 1 diabetes treatment. Researchers at Harvard University have successfully generated functional beta cells from embryonic stem cells that can regulate blood glucose levels when transplanted into diabetic mice. This research offers hope for the approximately 1.6 million Americans living with Type 1 diabetes.
The field of embryonic stem cell research operates within a complex ethical and regulatory framework in the United States. While federal funding restrictions have historically limited research scope, private institutions and state-funded programs, particularly in California and New York, have continued advancing the field. Understanding these ethical dimensions is essential for students considering careers in biomedical research or healthcare policy.
Related Micro-courses